Uploaded April 2026 | Updated September 2026, 6 hours ago
The Johns Hopkins Bloomberg School of Public Health hosted a media briefing on April 8, 2026, to discuss the rollout of new malaria vaccines, the global state of malaria, including recent trends in cases, and the potential impact of shifting global health funding. Malaria is a mosquito-borne disease that in 2024 took more than 600,000 lives globally.
Topics discussed:
The rollout of malaria vaccines and treatments across African countries and key milestones achieved.
New tools to track vaccine introduction, including the IVAC malaria vaccine tracker.
The current global state of malaria and recent increases in cases in specific countries.
Early indications of how reductions in U.S. funding may influence malaria control, leading to an increase in cases and deaths.
How funding changes may affect countries’ ability to expand access to malaria vaccines.
What these developments mean for global malaria control efforts in 2026 and beyond.
Insights from:
Jane M. Carlton, PhD, director of the Johns Hopkins Malaria Research Institute at the Johns Hopkins Bloomberg School of Public Health and a Bloomberg Distinguished Professor in the Department of Molecular Microbiology and Immunology at the School and in the Department of Biomedical Engineering at the Johns Hopkins Whiting School of Engineering. Her research uses comparative and integrative multi-molecular approaches to further understand the biology and evolution of malaria parasites and their mosquito vectors.
William Moss, MD, a professor in the departments of Epidemiology and International Health at the Johns Hopkins Bloomberg School of Public Health; deputy director of the Johns Hopkins Malaria Research Institute; and executive director at the School’s International Vaccine Access Center. His research focuses on the epidemiology and control of malaria in southern Africa.
Resources:
Jane M. Carlton
https://publichealth.jhu.edu/faculty/1515/jane-m-carlton
William Moss
https://publichealth.jhu.edu/faculty/497/william-john-moss
Johns Hopkins Malaria Research Institute
https://publichealth.jhu.edu/malaria-research-institute
International Vaccine Access Center
https://publichealth.jhu.edu/ivac
World Malaria Day Symposium 2026 | Johns Hopkins
https://publichealth.jhu.edu/malaria-research-institute/2026-world-malaria-day-symposium-and-jhmri-25th-anniversary-0
Current Vaccine Introduction Status
view-hub.org/vaccine/malaria
FACTSHEET | Malaria Research Institute
https://publichealth.jhu.edu/malaria-research-institute/factsheet
Discovery of Mosquito Molecular Mechanism Opens Door to New Antimalaria Strategies
https://publichealth.jhu.edu/2025/discovery-of-mosquito-molecular-mechanism-opens-door-to-new-antimalaria-strategies
Natural ‘Biopesticide’ Against Malaria Mosquitoes Successful in Early Field Tests
https://publichealth.jhu.edu/2024/natural-biopesticide-against-malaria-mosquitoes-successful-in-early-field-tests
What Genomics Can Reveal about Malaria’s Recent U.S. Appearance (with Jane Carlton)
johnshopkinsmalariaminute.libsyn.com/extended-what-genomics-can-reveal-about-malarias-recent-us-appearance-with-jane-carlton
Using Genomics to Track Malaria in the U.S.
https://publichealth.jhu.edu/2023/tracking-malaria-in-the-us
Editing Out Malaria, One Mosquito at a Time
https://publichealth.jhu.edu/2022/editing-out-malaria-one-mosquito-at-a-time
A New Malaria Treatment May Offer Long-Awaited Alternative to Artemisinin
globalhealthnow.org/2025-11/music-our-ears-new-malaria-treatment-may-offer-long-awaited-alternative-artemisinin
Southern Africa ICEMR: Harnessing Innovation to Transform Malaria Surveillance into Key Interventions Across Transmission Settings in Zambia
niaid.nih.gov/research/southern-africa-icemr-harnessing-innovation-transform-malaria-surveillance-key
Timestamps:
0:00 Introduction
01:45 Global status of malaria
05:36 Status of malaria vaccines
10:16 Malaria in countries without new vaccines
11:25 Vaccines and funding
13:26 New tools to tackle malaria in Africa
15:20 Effectiveness of multilateral organizations
17:16 Parasites evading vaccines
18:46 Vaccines for travelers and military personnel
20:20 Pesticide-resistant mosquitos in Zimbabwe
22:44 Key drivers of malaria trends
24:34 Genomic surveillance
26:04 Malaria trackers
27:16 Risks to malaria-control programs
28:44 Closing remarks
https://publichealth.jhu.edu
instagram.com/JohnsHopkinsSPH
facebook.com/JohnsHopkinsSPH
twitter.com/johnshopkinssph
The Johns Hopkins Bloomberg School of Public Health hosted a media briefing on April 8, 2026, to discuss the rollout of new malaria vaccines, the global state of malaria, including recent trends in cases, and the potential impact of shifting global health funding. Malaria is a mosquito-borne disease that in 2024 took more than 600,000 lives globally.
Topics discussed:
The rollout of malaria vaccines and treatments across African countries and key milestones achieved.
New tools to track vaccine introduction, including the IVAC malaria vaccine tracker.
The current global state of malaria and recent increases in cases in specific countries.
Early indications of how reductions in U.S. funding may influence malaria control, leading to an increase in cases and deaths.
How funding changes may affect countries’ ability to expand access to malaria vaccines.
What these developments mean for global malaria control efforts in 2026 and beyond.
Insights from:
Jane M. Carlton, PhD, director of the Johns Hopkins Malaria Research Institute at the Johns Hopkins Bloomberg School of Public Health and a Bloomberg Distinguished Professor in the Department of Molecular Microbiology and Immunology at the School and in the Department of Biomedical Engineering at the Johns Hopkins Whiting School of Engineering. Her research uses comparative and integrative multi-molecular approaches to further understand the biology and evolution of malaria parasites and their mosquito vectors.
William Moss, MD, a professor in the departments of Epidemiology and International Health at the Johns Hopkins Bloomberg School of Public Health; deputy director of the Johns Hopkins Malaria Research Institute; and executive director at the School’s International Vaccine Access Center. His research focuses on the epidemiology and control of malaria in southern Africa.
Resources:
Jane M. Carlton
https://publichealth.jhu.edu/faculty/1515/jane-m-carlton
William Moss
https://publichealth.jhu.edu/faculty/497/william-john-moss
Johns Hopkins Malaria Research Institute
https://publichealth.jhu.edu/malaria-research-institute
International Vaccine Access Center
https://publichealth.jhu.edu/ivac
World Malaria Day Symposium 2026 | Johns Hopkins
https://publichealth.jhu.edu/malaria-research-institute/2026-world-malaria-day-symposium-and-jhmri-25th-anniversary-0
Current Vaccine Introduction Status
view-hub.org/vaccine/malaria
FACTSHEET | Malaria Research Institute
https://publichealth.jhu.edu/malaria-research-institute/factsheet
Discovery of Mosquito Molecular Mechanism Opens Door to New Antimalaria Strategies
https://publichealth.jhu.edu/2025/discovery-of-mosquito-molecular-mechanism-opens-door-to-new-antimalaria-strategies
Natural ‘Biopesticide’ Against Malaria Mosquitoes Successful in Early Field Tests
https://publichealth.jhu.edu/2024/natural-biopesticide-against-malaria-mosquitoes-successful-in-early-field-tests
What Genomics Can Reveal about Malaria’s Recent U.S. Appearance (with Jane Carlton)
johnshopkinsmalariaminute.libsyn.com/extended-what-genomics-can-reveal-about-malarias-recent-us-appearance-with-jane-carlton
Using Genomics to Track Malaria in the U.S.
https://publichealth.jhu.edu/2023/tracking-malaria-in-the-us
Editing Out Malaria, One Mosquito at a Time
https://publichealth.jhu.edu/2022/editing-out-malaria-one-mosquito-at-a-time
A New Malaria Treatment May Offer Long-Awaited Alternative to Artemisinin
globalhealthnow.org/2025-11/music-our-ears-new-malaria-treatment-may-offer-long-awaited-alternative-artemisinin
Southern Africa ICEMR: Harnessing Innovation to Transform Malaria Surveillance into Key Interventions Across Transmission Settings in Zambia
niaid.nih.gov/research/southern-africa-icemr-harnessing-innovation-transform-malaria-surveillance-key
Timestamps:
0:00 Introduction
01:45 Global status of malaria
05:36 Status of malaria vaccines
10:16 Malaria in countries without new vaccines
11:25 Vaccines and funding
13:26 New tools to tackle malaria in Africa
15:20 Effectiveness of multilateral organizations
17:16 Parasites evading vaccines
18:46 Vaccines for travelers and military personnel
20:20 Pesticide-resistant mosquitos in Zimbabwe
22:44 Key drivers of malaria trends
24:34 Genomic surveillance
26:04 Malaria trackers
27:16 Risks to malaria-control programs
28:44 Closing remarks
https://publichealth.jhu.edu
instagram.com/JohnsHopkinsSPH
facebook.com/JohnsHopkinsSPH
twitter.com/johnshopkinssph
